Procter & Gamble Health logo

Procter & Gamble Health Q1 results, quarter to Jun 2026

NSE: PGHLBSE: 500126Pharmaceuticals & BiotechnologySmall Cap

Procter & Gamble Health Limited · Formerly Merck · Face value ₹10 · Listed Jan 1982 on BSE, Apr 1996 on NSE
Last close ₹5,513.50up ₹114.50 (2.12%)BSE ₹5,510.60

Share price at the NSE close on 29 Oct 2026. Previous close ₹5,399.00.

29 Oct: open ₹5,399.00, high ₹5,540.00, low ₹5,380.50

52-week range of traded prices to 29 Oct 2026
₹4,707.00Low, 6 Apr 2026₹6,975.00High, 15 Jul 2026
Market cap
₹9,152 Cr585th largest listed
P/E
25.64
P/B
17.45
Dividend yield
3.72%
ROE
67.2%
ROCE
84.2%
Debt to equity
0.00
Volume, NSE
5,66357.6% delivered

Procter & Gamble Health filed its Q1 results for the quarter to Jun 2026 on 6 Aug 2026 at 6:14 pm, standalone: the listed company alone, without its subsidiaries.

Q1 results, quarter to Jun 2026

₹ crore.Procter & Gamble Health annual results and balance sheet

Revenue
₹364 Cr+7.4% on a year ago · −1.8% on the quarter before
Operating profit
₹100 Cr+10.3% on a year ago · −26.5% on the quarter before
Net profit
₹96 Cr+45.3% on a year ago · +1.6% on the quarter before
Earnings per share
₹57.92+45.3% on a year ago · +1.6% on the quarter before
Operating margin
27.4%
Net margin
26.4%

From revenue to net profit, ₹ crore

  1. Revenue364
  2. Materials and goods−96
  3. Employee costs−60
  4. Other expenses−108
  5. Operating profit100
  6. Depreciation−6.0
  7. Other income+3.9
  8. One-off items+32
  9. Finance costs−0.1
  10. Profit before tax129
  11. Tax−33
  12. Net profit96

Procter & Gamble Health results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
30566Sep 2331072Dec 2325247Mar 2428417Jun 2431382Sep 2431091Dec 24Mar 2533966Jun 2532589Sep 2537478Dec 2537095Mar 2636496Jun 26
Peak revenue ₹374 Cr, quarter to Dec 2025; lowest ₹252 Cr, quarter to Mar 2024

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
39.8%5.9%29.1%32.8%26.7%17.0%36.4%39.8%26.7%37.0%29.5%36.6%27.4%21.5%23.3%18.4%5.9%26.3%29.3%19.5%27.2%20.8%25.5%26.4%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Jun 26
₹ croreSep 2021Q1Filed 9 NovDec 2021Mar 2022Q3Jun 2022Sep 2022Q1Dec 2022Mar 2023Q3Jun 2023Sep 2023Q1Dec 2023Mar 2024Q3Jun 2024Sep 2024Filed 4 NovDec 2024Mar 2025Jun 2025Q1Sep 2025Q2Dec 2025Q3Mar 2026Q4Jun 2026Q1Filed 6 Aug
Revenue from operations273278268296298310321301305310252284313310–339325374370364
195216199236207200243256216208185236199186–248205263235264
Materials and goods bought83908189868110094879074798876–94681109396
Employee costs4041454243476155615748494647–5654625160
Other expenses7385731057771831076861631086564–98829291108
Operating profit before depreciation78626960911107845891026748114123–90120110136100
Operating margin28.6%22.3%25.7%20.2%30.5%35.6%24.2%15.0%29.1%32.8%26.7%17.0%36.4%39.8%–26.7%37.0%29.5%36.6%27.4%
Depreciation and amortisation776871046677766–56666
Other income35233555652234–45444
Finance costs00000000000000–00000
Profit before one-off items and tax74606555871057944881006343111122–8911910913397
One-off items00000000000−2000–000032
Profit before tax74606555871057944881006323111122–89119109133129
191514132328191422281662931–2330313933
Tax rate25.2%25.1%21.1%24.6%26.5%26.8%24.6%32.4%25.5%27.7%25.8%26.5%26.1%25.3%–25.5%25.6%28.7%29.0%25.5%
Net profit5545514164775930667247178291–6689789596
Other comprehensive income0−3120−420−111−10−2–−121−30
Total comprehensive income5542524464736130657348168389–6691789296
Net margin20.3%16.1%19.1%13.9%21.4%24.8%18.4%9.9%21.5%23.3%18.4%5.9%26.3%29.3%–19.5%27.2%20.8%25.5%26.4%
Earnings per share₹33.40₹27.00₹30.80₹24.80₹38.30₹46.30₹35.70₹17.96₹39.50₹43.40₹28.00₹10.11₹49.60₹54.76–₹39.87₹53.34₹46.74₹56.99₹57.92
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Mar 2025.